Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy

Ying Jing(The University of Texas Health Science Center at Houston), Leng Han(Prevention Institute)

Nature Communications

October 2, 2020

10.1038/s41467-020-18742-9

Cited by 206

Related Papers

Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer

|Nature Communications|2019|297

Multi-omics characterization of autophagy-related molecular features for therapeutic targeting of autophagy

|Nature Communications|2022|37

Concomitant BET and MAPK blockade for effective treatment of ovarian cancer

|Oncotarget|2015|34

Macroautophagy/autophagy promotes resistance to KRASG12D-targeted therapy through glutathione synthesis

|Cancer Letters|2024|22

Identification of Hypoxia‐<i>ALCAM</i><sup>high</sup> Macrophage‐ Exhausted T Cell Axis in Tumor Microenvironment Remodeling for Immunotherapy Resistance

|Advanced Science|2024|17